Much of the nutritional epidemiology evaluating the role of diet and cancer risk has historically focused on solid foods, and only a paucity of the literature has considered beverage consumption. Patterns of beverage consumption vary widely throughout the world. Whereas water is the primary beverage consumed, intake of tea and coffee is also common, and sweetened beverage intake has increased considerably in recent decades, especially in the United States and Europe (1) . These beverages can, in some individuals or populations, contribute notably to total energy intake. Coffee and tea are commonly adulterated with high-fat creamer or milk and sweeteners; sweetened beverages provide approximately 13 kcal/oz and provide little to no nutritional value.
In this issue of the Journal, Zhang et al. (2) evaluate the role of coffee, tea, and sweetened beverage intake and risk for colon cancer using a pooled analysis that includes data collected from 13 prospective cohort studies. The pooled analyses showed a null association for coffee intake and risk of colon cancer, consistent with the larger body of evidence available to date (3); however, a modest increase in risk of colon cancer was shown for tea consumption. Intake of sweetened beverages was not associated with risk of colon cancer. Of note, the authors did not evaluate intake of juices, which are energy-containing nutrient-rich beverages.
The null results for sweetened beverage intake and colorectal cancer from the pooled analysis (2) contribute valuable information, given the paucity of literature in this area. These results are particularly important, given the substantial increase in sweetened beverage consumption that has occurred over the past 50 years worldwide (4, 5) . Intake of these beverages, and more specifically, the fructose content, has been suggested to contribute to greater caloric intake (6) and body weight (7), risk indicators for metabolic syndrome (8, 9) , and possibly overall reduced nutrient density of the diet (10) . Importantly, these factors also have been associated with risk of colon cancer and mortality (11) (12) (13) (14) (15) (16) . The findings in the study by Zhang et al. (2) may be partially explained by the fact that the studies in the pooled analyses are capturing an exposure that is relatively recent. Contrary to coffee and tea consumption, intake of sweetened beverages begins in childhood in many countries (17) . Furthermore, sweetened beverage consumption is generally much lower among older adults (4). These differences in exposure suggest that intake of sweetened beverages may need to be assessed earlier in life to adequately assess its association with health outcomes. Thus, any deleterious effect related to the association between colorectal cancer and consumption of sweetened beverages might not immediately manifest itself if a long induction period is needed, as is the case for the inverse associations demonstrated for aspirin and nonsteroidal anti-inflammatory drug use (18) or multivitamin use (19) ; for these exposures, the association is only evident a decade or more following exposure.
The pooled analysis by Zhang et al. (2) showed that tea intake of greater than 32 oz/day was associated with a statistically significant, yet modest, increased risk for colon cancer as compared with no consumption. Whether this association is real or not is unknown. Importantly, the pooled analysis did not include populations from Asia, where tea intake contributes a very different exposure than for the United States and European populations, because of higher consumption and generally a lifelong daily intake of green tea. The most plausible explanation for the positive association between tea consumption and risk of colorectal cancer in the pooled analyses probably relates to chance or bias. Given the weak relative risk observed, the association is likely a spurious finding because of confounding, where tea consumption may be associated with deleterious behaviors, such as greater intake of high-caloric baked goods or pastries; accompaniments to tea consumption were not available for evaluation. Furthermore, given that only 2% of the overall pooled population reported tea intake at the highest level, where the positive association was observed, the statistically significant association could be due to a type 1 error resulting in a false-positive finding.
Plausible mechanism-based hypotheses in support of the evaluating associations between coffee and tea consumption and risk of colorectal cancer exist; however, the biology may point to opposing carcinogenesis effects. For example, coffee contains a complex mix of health-promoting as well as risk-enhancing compounds (20) . Caffeine, a principal component of coffee, can enhance gut motility (reducing carcinogen exposure time) (21) and inhibit signaling pathways associated with colorectal cancer progression (22) . However, data based on in vitro models (23) show that caffeine is also capable of enhancing mutagenicity. Tea is rich in cancer-protective polyphenols (24) but provides a source of potentially cancer-promoting polyamines (25) , which may contribute to an increase in risk for colorectal neoplasia (26) .
The opposing cancer-associated mechanisms of action recognized for coffee, tea, or the compounds therein underscore the challenges in assessing risk of cancer in epidemiological studies relying on dietary questionnaires. Beyond the known inaccuracies of self-reported diet, particularly those based on food-frequency questionnaire estimates of intake (27, 28) , the specific case of beverage intake must be considered. In addition, error in exposure estimates related to international differences in portion sizes, variability in beverage types and preparation methods, and sweeteners and/or flavor-enhancers added at the time of consumption further challenge our ability to assess their intake accurately. It could be hypothesized that null results based on these studies are the result of countering carcinogenesis influences leading to a net overall null association or that weak associations are attenuated because of measurement error.
Assessment of risk of cancer associated with beverage intake will continue to be challenging. Arguably, improvements in measurement, including duration of exposure, and a better understanding of the timing and latency period could improve our understanding of these complex associations. Addressing these limitations should form the basis for future studies.
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